4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-062779
Chief Executive Officer sold 90,000 shares at $14.07 ($1,266,300)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2018-12-12 | Sale | −90,000 | $14.07 | $1,266,300 | 1,632,455 | D |
| Open-market sales · 90,000 sh · avg $14.07 · $1,266,300 | |||||||
Loading xslF345X03/doc4.xml…